ゲノミクスにおける人工知能市場：提供、機能、用途、エンドユーザー別-2025-2030年の世界予測

ゲノミクスにおける人工知能市場は、2023年に5億6,007万米ドルと評価され、2024年には7億4,023万米ドルに達すると予測され、CAGR 32.65％で成長し、2030年には40億4,830万米ドルに達すると予測されています。

ゲノミクスにおける人工知能（AI）産業は、AI技術を活用して遺伝子データを分析し、ゲノム研究を強化することで、個別化医療、創薬、疾病予測に貴重な洞察を提供します。ゲノミクスにおけるAIの範囲は、データ駆動型のヘルスケアソリューション、ゲノム診断の改善、画期的な遺伝子研究にまで及び、医学の進歩に欠かせないです。その必要性は、解釈のために高度な計算モデルを必要とする膨大な量のゲノム・データが生成されることによって強調されています。AIは複雑なデータ処理を簡素化し、分析の迅速化とより正確な結果を提供します。その用途は、ゲノム配列データの管理、AIを活用した遺伝性疾患の診断、個別化治療計画の策定など多岐にわたる。最終用途はヘルスケアプロバイダー、製薬会社、研究所、学術機関など多岐にわたる。市場の成長は、精密医療に対する需要の増加、AI技術の進歩、ゲノム研究に対する関心の高まりに影響されています。最新のビジネスチャンスは、AIと次世代シークエンシング技術の統合や、AI主導の遺伝子編集ツールの可能性にあります。企業にとっての戦略的提言としては、AIプラットフォーム開発への投資や、イノベーションを推進するための生物医学研究者や技術専門家との共同パートナーシップが挙げられます。しかし、この市場は、データプライバシーに関する懸念、規制上のハードル、導入コストの高さ、AIモデルとその結果の強固な検証の必要性など、大きな課題に直面しています。これらの制約を克服するには、透明性の高いAIシステムを開発し、倫理基準を遵守することに注力する必要があります。技術革新と研究に最適な分野としては、複雑な遺伝的相互作用の解明におけるAIの役割の探求や、予測ゲノミクスのためのツールの開発が挙げられます。情勢が急速に進化する中、利害関係者は規制環境を乗り切り、ゲノミクスにおけるAIの可能性を最大限に活用するために機敏であり続けなければならないです。ダイナミックな性質を持つこの市場は、新たな技術的進歩に貢献する企業にとって大きな可能性を秘めています。

市場力学：急速に進化するゲノミクスにおける人工知能市場の主要市場インサイトを公開

ゲノミクスにおける人工知能市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 創薬と医薬品開発に起因する潜在需要
  • 製薬・バイオテクノロジー業界における自動化システムの採用増加
  • ゲノムソリューションによる新薬発見への継続的投資
• 市場抑制要因
  • AIの開発・導入に伴う高コスト
• 市場機会
  • 臨床試験データ管理におけるAIの適応性の高まりと高品質なデータ生成
  • ゲノミクス分野におけるAI導入に向けた政府のイニシアティブの高まり
• 市場の課題
  • ゲノミクスにおけるAIに関連する熟練専門家の不足とデータセキュリティの課題

ポーターのファイブフォース：ゲノミクスにおける人工知能市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ゲノミクスにおける人工知能市場における外部からの影響の把握

外部マクロ環境要因は、ゲノミクスにおける人工知能市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ゲノミクスにおける人工知能市場における競合情勢の把握

ゲノミクスにおける人工知能市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスゲノミクスにおける人工知能市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ゲノミクスにおける人工知能市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ゲノミクスにおける人工知能市場における成功への道筋を描く

ゲノミクスにおける人工知能市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 医薬品の発見と開発による潜在的需要
    • 製薬およびバイオテクノロジー業界における自動化システムの導入増加
    • ゲノムソリューションによる新薬発見への継続的な投資
  • 抑制要因
    • AIの開発と導入に伴う高コスト
  • 機会
    • 臨床試験データ管理と高品質データ生成におけるAIの適応性の向上
    • ゲノミクス分野におけるAI導入に向けた政府の取り組みが活発化
  • 課題
    • ゲノミクスにおけるAIに関連する熟練した専門家の不足とデータセキュリティの課題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ゲノミクスにおける人工知能市場：提供別

• サービス
• ソフトウェア

第7章 ゲノミクスにおける人工知能市場：機能別

• 臨床ワークフロー
• 遺伝子編集
• ゲノム配列解析
• 予測遺伝子検査と予防医学

第8章 ゲノミクスにおける人工知能市場：用途別

• 農業と動物調査
• 診断
• 医薬品の発見と開発
• 精密医療

第9章 ゲノミクスにおける人工知能市場：エンドユーザー別

• 政府機関
• ヘルスケア提供者
• 製薬・バイオテクノロジー企業
• 研究センターおよび学術機関

第10章 南北アメリカのゲノミクスにおける人工知能市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のゲノミクスにおける人工知能市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのゲノミクスにおける人工知能市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• BenevolentAI Ltd.
• Data4Cure Inc.
• Deep Genomics Inc.
• DNAnexus Inc.
• Engine Biosciences Pte. Ltd.
• Exscientia
• Fabric Genomics Inc.
• FDNA Inc.
• Freenome Holdings, Inc.
• Genomics AI
• Genoox Ltd.
• Illumina, Inc.
• insitro
• International Business Machines Corporation
• Invitae Corporation
• LGC Biosearch Technologies
• Lifebit Biotech Ltd
• Microsoft Corporation
• MolecularMatch, Inc.
• NVIDIA Corporation
• Ocean Genomics
• Owkin, Inc
• PrecisionLife Ltd.
• Sophia Genetics SA
• Verge Genomics

LIST OF FIGURES

• FIGURE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET RESEARCH PROCESS
• FIGURE 2. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY CLINICAL WORKFLOWS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PREDICTIVE GENETIC TESTING & PREVENTIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY GOVERNMENT ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY HEALTHCARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 39. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 61. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. CHINA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 65. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 134. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. ITALY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 150. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. POLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 154. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. QATAR ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. ARTIFICIAL INTELLIGENCE IN GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

The Artificial Intelligence in Genomics Market was valued at USD 560.07 million in 2023, expected to reach USD 740.23 million in 2024, and is projected to grow at a CAGR of 32.65%, to USD 4,048.30 million by 2030.

The artificial intelligence (AI) in genomics industry involves leveraging AI technologies to analyze genetic data and enhance genomic research, offering invaluable insights into personalized medicine, drug discovery, and disease prediction. The scope of AI in genomics extends across data-driven healthcare solutions, improved genomic diagnostics, and groundbreaking genetic research, crucial for advancing medical science. Its necessity is underscored by the vast amount of genomic data generated that requires sophisticated computational models for interpretation. AI simplifies complex data processing, providing accelerated analysis and more precise outcomes. The applications span the management of genomic sequencing data, AI-powered diagnostics for genetic disorders, and the development of personalized treatment plans. End-use scope is vast, targeting healthcare providers, pharmaceutical companies, research laboratories, and academic institutions. Market growth is being influenced by increasing demand for precision medicine, advancements in AI technologies, and a rising interest in genomic research. The latest opportunities lie in the integration of AI with next-generation sequencing technologies and the potential for AI-driven gene editing tools. For businesses, strategic recommendations include investing in AI platform development and collaborative partnerships with biomedical researchers and technology experts to drive innovation. However, the market faces significant challenges, including data privacy concerns, regulatory hurdles, high costs of implementation, and a need for robust validation of AI models and their outcomes. Overcoming these limitations requires a focus on developing transparent AI systems and adhering to ethical standards. The best areas for innovation and research include exploring AI's role in dissecting complex genetic interactions and developing tools for predictive genomics. As the landscape rapidly evolves, stakeholders must remain agile to navigate regulatory environments and harness AI's full potential in genomics. With its dynamic nature, the market presents substantial possibilities for businesses poised to contribute to its emerging technological advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Intelligence in Genomics Market

The Artificial Intelligence in Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Potential demand attributed to drug discovery and drug developments
  • Increasing adoption of automated systems in pharmaceuticals and biotechnology industries
  • Ongoing investments in novel drug discoveries with genomic solutions
• Market Restraints
  • High costs associated with development and deployment of AI
• Market Opportunities
  • Growing adaptability of AI for clinical trials data management along with high-quality data generation
  • Upsurging governmental initiatives for AI deployment in genomics
• Market Challenges
  • Scarcity of skilled professionals and data security challenges associated with AI in genomics

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Intelligence in Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Intelligence in Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Intelligence in Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Intelligence in Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Intelligence in Genomics Market

A detailed market share analysis in the Artificial Intelligence in Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Intelligence in Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Intelligence in Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Intelligence in Genomics Market

A strategic analysis of the Artificial Intelligence in Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Genomics Market, highlighting leading vendors and their innovative profiles. These include BenevolentAI Ltd., Data4Cure Inc., Deep Genomics Inc., DNAnexus Inc., Engine Biosciences Pte. Ltd., Exscientia, Fabric Genomics Inc., FDNA Inc., Freenome Holdings, Inc., Genomics AI, Genoox Ltd., Illumina, Inc., insitro, International Business Machines Corporation, Invitae Corporation, LGC Biosearch Technologies, Lifebit Biotech Ltd, Microsoft Corporation, MolecularMatch, Inc., NVIDIA Corporation, Ocean Genomics, Owkin, Inc, PrecisionLife Ltd., Sophia Genetics SA, and Verge Genomics.

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Services and Software.
• Based on Function, market is studied across Clinical Workflows, Gene Editing, Genome Sequencing, and Predictive Genetic Testing & Preventive Medicine.
• Based on Application, market is studied across Agriculture & Animal Research, Diagnostics, Drug Discovery & Development, and Precision Medicine.
• Based on End-User, market is studied across Government Organizations, Healthcare Providers, Pharmaceutical & Biotech Companies, and Research Centers & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Potential demand attributed to drug discovery and drug developments
    • 5.1.1.2. Increasing adoption of automated systems in pharmaceuticals and biotechnology industries
    • 5.1.1.3. Ongoing investments in novel drug discoveries with genomic solutions
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with development and deployment of AI
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing adaptability of AI for clinical trials data management along with high-quality data generation
    • 5.1.3.2. Upsurging governmental initiatives for AI deployment in genomics
  • 5.1.4. Challenges
    • 5.1.4.1. Scarcity of skilled professionals and data security challenges associated with AI in genomics
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Artificial Intelligence in Genomics Market, by Offering

• 6.1. Introduction
• 6.2. Services
• 6.3. Software

7. Artificial Intelligence in Genomics Market, by Function

• 7.1. Introduction
• 7.2. Clinical Workflows
• 7.3. Gene Editing
• 7.4. Genome Sequencing
• 7.5. Predictive Genetic Testing & Preventive Medicine

8. Artificial Intelligence in Genomics Market, by Application

• 8.1. Introduction
• 8.2. Agriculture & Animal Research
• 8.3. Diagnostics
• 8.4. Drug Discovery & Development
• 8.5. Precision Medicine

9. Artificial Intelligence in Genomics Market, by End-User

• 9.1. Introduction
• 9.2. Government Organizations
• 9.3. Healthcare Providers
• 9.4. Pharmaceutical & Biotech Companies
• 9.5. Research Centers & Academic Institutes

10. Americas Artificial Intelligence in Genomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Artificial Intelligence in Genomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Genomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. BenevolentAI Ltd.
• 2. Data4Cure Inc.
• 3. Deep Genomics Inc.
• 4. DNAnexus Inc.
• 5. Engine Biosciences Pte. Ltd.
• 6. Exscientia
• 7. Fabric Genomics Inc.
• 8. FDNA Inc.
• 9. Freenome Holdings, Inc.
• 10. Genomics AI
• 11. Genoox Ltd.
• 12. Illumina, Inc.
• 13. insitro
• 14. International Business Machines Corporation
• 15. Invitae Corporation
• 16. LGC Biosearch Technologies
• 17. Lifebit Biotech Ltd
• 18. Microsoft Corporation
• 19. MolecularMatch, Inc.
• 20. NVIDIA Corporation
• 21. Ocean Genomics
• 22. Owkin, Inc
• 23. PrecisionLife Ltd.
• 24. Sophia Genetics SA
• 25. Verge Genomics